Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
Understanding the molecular basis of binding informs ways to prevent retroviral replication, including the HIV retrovirus.
This national honor recognizes Kearney’s distinguished contributions to immunology.
Up to now, it has not been clear if these cells might be useful to combat influenza infections or even if they exist at all.
The $30 million gift will go into an endowment — creating a yearly flexible fund of about $1.5 million that leadership of the cancer center and UAB School of Medicine can use in ways that best leverage further advancement of the cancer center.
Safe and effective therapeutic agents that can treat these cancer-causing viruses are greatly needed.
This Ph.D. training targets a Department of Education “area of national need.”
This finding may point to a therapeutic target to treat tuberculosis, which kills 1.3 million people each year.
An animal model for mild traumatic brain injury shows microscopic neuropathology, as well as neurophysiological and biochemical changes.
Findings show that mitochondrial DNA may strongly influence cellular metabolism and susceptibility to metabolic diseases like heart failure or obesity.
A study of how experimental inhibitors bind a key flu protein may guide novel antiviral compounds.